Vanillin derivatives as antifungal agents against Aspergillus fumigatus : in vitro activity, in vivo efficacy, and mechanistic insights
Canadian Journal of Microbiology · 2026
DOI: 10.1139/cjm-2025-0295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Microbiology, 2026. Verfasst von Orlando Flores-Maldonado und 5 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Autónoma de Nuevo León, Departamento de Microbiología, Facultad de Medicina y Hospital Universitario "Dr. José Eleuterio González," Monte…. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Benzaldehydes, Antifungal Agents, Aspergillosis. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Programa de Apoyo a la Ciencia, Tecnología e Innovación.
Abstract (Originalsprache)
The World Health Organization includes Aspergillus fumigatus on the list of fungal pathogens of critical priority for the development of new therapeutic options, due to the emergence of antifungal-resistant strains and high mortality rates. This work evaluated the antifungal activity of vanillin, o-vanillin, ethyl vanillin, and vanillin acetate against A. fumigatus. Broth microdilution assays were performed to determine the minimum inhibitory concentrations of the phenolic compounds. Moreover, the ability of vanillin and its derivatives to inhibit conidial adhesion and biofilm formation at subinhibitory concentrations was assessed. The possible mechanism of action of the compounds by molecular docking was evaluated. Finally, the therapeutic efficacy of the molecules was analyzed in an in vivo aspergillosis model. Vanillin and its derivatives exhibited antifungal effects against A. fumigatus at concentrations of 0.25–1 mmol/L; notably, o-vanillin showed higher antifungal activity (0.25 mmol/L). Furthermore, vanillin, o-vanillin, and vanillin acetate reduced conidial adhesion and biofilm formation at subinhibitory concentrations. These compounds decreased ergosterol concentration, and in silico analysis showed that phenolic compounds interact with ERG5, ERG6, and ERG11. Vanillin and o-vanillin demonstrated therapeutic efficacy against an aspergillosis model. Overall, these results highlight the antifungal activity of vanillin and o-vanillin against A. fumigatus as a potential therapeutic alternative.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidad Autónoma de Nuevo León, Departamento de Microbiología, Facultad de Medicina y Hospital Universitario "Dr. José Eleuterio González," Monterrey, 64460 Nuevo León, México.
- Universidad Autónoma de Nuevo León, Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, San Nicolás de los Garza, 66455 Nuevo León, México.
ORCID-Profile: Orlando Flores-Maldonado, Jorge Dávila-Aviña, Ana L Ríos-López
Förderung
- Programa de Apoyo a la Ciencia, Tecnología e Innovación
Zitieren
APA
Flores-Maldonado, O., de Anda-Mora, K., Jiménez-Barrientos, J., Dávila-Aviña, J., Muñiz-Bernal, V., & Ríos-López, A. (2026). Vanillin derivatives as antifungal agents against Aspergillus fumigatus : in vitro activity, in vivo efficacy, and mechanistic insights. Canadian Journal of Microbiology. https://doi.org/10.1139/cjm-2025-0295
Vancouver
Flores-Maldonado O, de Anda-Mora K, Jiménez-Barrientos J, Dávila-Aviña J, Muñiz-Bernal V, Ríos-López A. Vanillin derivatives as antifungal agents against Aspergillus fumigatus : in vitro activity, in vivo efficacy, and mechanistic insights. Canadian Journal of Microbiology. 2026. doi:10.1139/cjm-2025-0295
BibTeX
@article{FloresMaldonado2026,
author = {Flores-Maldonado, Orlando and de Anda-Mora, Karla and Jiménez-Barrientos, Jimena G and Dávila-Aviña, Jorge and Muñiz-Bernal, Valeria and Ríos-López, Ana L},
title = {Vanillin derivatives as antifungal agents against Aspergillus fumigatus : in vitro activity, in vivo efficacy, and mechanistic insights},
journal = {Canadian Journal of Microbiology},
year = {2026},
doi = {10.1139/cjm-2025-0295}
}
EUVIMED